+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

France Silent Heart Attack Market 2020-2026

  • PDF Icon


  • August 2020
  • Region: France
  • Orion Market Research Private Limited
  • ID: 5148101
France Silent Heart Attack Market Size, Share & Trends Analysis Report by Diagnosis (Electrocardiography (ECG), MRI, Computed Tomography (CT Scan), Echocardiography, and Others), by Treatment (Medication and Surgery), and by End-User (Hospitals & Clinics and Ambulatory Surgical Centers) and Forecast, 2020-2026.

France silent heart attack market is estimated to grow considerably, at a CAGR of around 4% during the forecast period. France has a quality healthcare system and favorable government policies which are boosting the silent heart attack market in the country. France is one of the largest economies of the EU, generating huge revenues in the cardiology domain. The increasing adoption of innovative cardiology devices such as innovative cardiac stents, catheters, and guiding wires are anticipated to drive the growth of the silent heart attack market in France. As per the estimation of the National Centre for Biotechnology Information (NCBI), around 15-20% population of France is suffering from obesity and overweight diseases, which may lead to heart diseases. Obese, diabetic, and hypertension patients are likely to develop CVD diseases and other heart diseases. Therefore, France contributes a significant share in the global silent heart attack market.

France silent heart attack market is segmented into diagnosis, treatment, and end-user. Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest x-ray, computed tomography (CT Scan), echocardiography, and others (blood test). Based on treatment, the market is segmented into medication and surgery. Based on end-user, the market is segmented into hospitals & clinics and ambulatory surgical centers (ASCs). Echocardiography is commonly used for the investigation of the patient's heart attack. It can detect the accurate area of the heart muscles; areas that are not getting proper blood flow or the injured area from the previous heart attack.

The companies which are contributing to the growth of France silent heart attack market include AstraZeneca PLC, Bayer AG, Siemens AG, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim GmbH, and GlaxoSmithKline Plc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market.

Research Methodology:

The market study of France silent heart attack market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, various services offered by the players, and market opportunity. The report will serve as a source for 360-degree analysis of the market delivering insights for making better business decisions.

Market Segmentation:

1. France Silent Heart Attack Market Research and Analysis by Diagnosis
2. France Silent Heart Attack Market Research and Analysis by Treatment
3. France Silent Heart Attack Market Research and Analysis by End-User

The Report Covers:
  • Comprehensive research methodology of the France silent heart attack market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the France silent heart attack market.
  • Insights about market determinants which are stimulating the France silent heart attack market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. France Silent Heart Attack Market by Diagnosis
5.1.1. Electrocardiography (ECG)
5.1.2. Magnetic Resonance Imaging (MRI)
5.1.3. Computed Tomography (CT Scan)
5.1.4. Echocardiography
5.1.5. Others (Blood Test)
5.2. France Silent Heart Attack Market by Treatment
5.2.1. Medication
5.2.2. Surgery Angioplasty Bypass Surgery Heart Transplant
5.3. France Silent Heart Attack Market by End-Users
5.3.1. Hospital & Clinics
5.3.2. Ambulatory Surgical Centers
6. Company Profiles
6.1. Astellas Pharma Inc.
6.2. AstraZeneca PLC
6.3. Bayer AG
6.4. Boehringer Ingelheim GmbH
6.5. Boston Scientific Corp.
6.6. F. Hoffmann-La Roche Ltd.
6.7. GlaxoSmithKline Plc
6.9. Medtronic PLC
6.10. Merck & Co., Inc.
6.11. Novartis AG
6.12. Pfizer Inc.
6.13. Siemens AG
6.15. Takeda Pharmaceutical Co. Ltd.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corp.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Medtronic PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Siemens AG
  • Takeda Pharmaceutical Co. Ltd.